|
Shrimp
farming pioneer joins aquatic biotech leader
June 3, 2005
SAN DIEGO,
CA – Aqua Bounty Technologies, Inc., a Waltham, Massachusetts-based
company focused on enhancing aquaculture productivity through
the application of advanced biotechnologies, is pleased to announce
the appointment of Henry C. Clifford to the Animal Health and
Productivity Division of its Aqua Bounty Pacific subsidiary. Clifford,
a 25 year veteran of the $6-billion global shrimp farming industry,
will direct the deployment of the company’s portfolio of
therapeutics, diagnostic tools and health management products
into the marketplace as the ABT Vice President of Marketing and
Sales.
Clifford brings
a broad experience in commercial shrimp culture to his new position,
having played an instrumental role in the development and technical
direction of several of the largest shrimp farming ventures in
the western hemisphere. He pioneered the concept of shrimp domestication
and genetic stock improvement at a time when the industry was
still dependent on wild-caught broodstock and larvae. His contributions
to advancing the science of aquatic animal health management include
upgrades in pond preparation and feed management, and promoting
the use of disease-resistant and disease-free shrimp stocks.
“Henry
Clifford brings energy, experience and in-depth knowledge to the
task of advanced technology diffusion to the farm level,”
said Dr. Kurt Klimpel, the Chief Technology Officer at Aqua Bounty
Pacific. “His practical understanding of animal husbandry
and farm operations demonstrates Aqua Bounty’s commitment
to support the farmer in achieving superior results through productivity
improvements.”
“Aqua
Bounty has achieved an important product launch with the take-off
of its Shrimp IMS immunostimulant in Mexico,” Clifford said.
“Our farm clients report very significant survival improvements
with the recommended dosage and treatment timing, even in farms
which have suffered an infection of Taura Syndrome or White Spot
virus. I look forward to working directly with farmers to optimize
their performance with the product and to build on the Mexican
success to establish brand recognition for Aqua Bounty as a world
leader in aquatic animal health and productivity enhancement.”
In addition
to Shrimp IMS, Aqua Bounty Pacific provides high-sensitivity diagnostic
kits designed to detect as little as a single copy of target nucleic
acids under the SYBR Shrimp brand. Currently available in conventional
or real-time PCR configurations targeting 5 major shrimp viruses,
the company expects to add new kits targeting finfish pathogens
in the near future. A vaccine-like receptor blocker to prevent
White Spot infection is scheduled to enter field trials later
this year.
Back
to Press Release Archive
|
